If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


_____ Brought to you by WuXi AppTec_____

Self Service DNA Encoded Library Screening



  February 18, 2020

  8:00 a.m. PST, 11:00 a.m. EST, 16:00 GMT, 17:00 CET




WuXi AppTec’s DNA Encoded Library (DEL) service is a cutting-edge hit identification and optimization platform using an affinity-based selection method against DNA-Encoded small molecule libraries. The WuXi DEL collections in their entirety consist of more than 90 billion synthetic compounds, and the list continues to grow. With advanced bioinformatics systems to optimize client involvement in making collective decisions, WuXi offers proven success with nano-molar hits in various target classes and flexible business models to accommodate different needs.

One of these business models is DELight, WuXi’s self-serve product that gives researchers direct access to a collection of more than eight billion compounds. Through the DELight service package, WuXi provides a DEL kit and a user manual/protocols document to the research organization. Upon receipt of the kit, the researcher performs affinity selection according to the protocol and returns the sample to WuXi. WuXi then completes analysis such as PCR amplification, qPCR determination, purification and NGS (Next Generation Sequencing). A summary report (excluding structural and DNA sequence information) will be provided back to the researcher, who will make informed decision on follow up actions based on the selection results.

Brought to you by:

WuXi AppTec

Key Learning Objectives

  • Understand the current technologies enabling practical use of DNA encoded libraries.
  • Determine the potential to increase the volume of structures exposed to targets at an affordable cost.

Who Should Attend

  • Biochemists
  • Medicinal biologists
  • Medicinal chemists
  • Combinatorial chemists
  • Compound management


Alex Satz
Senior Director DEL Strategy and Operations at WuXi AppTec


Jeff Huber
Contributing Editor
C&EN Media Group